UK Markets close in 4 hrs 7 mins
  • FTSE 100

    6,921.81
    -78.27 (-1.12%)
     
  • FTSE 250

    22,338.90
    -151.96 (-0.68%)
     
  • AIM

    1,243.80
    -8.05 (-0.64%)
     
  • GBP/EUR

    1.1595
    -0.0022 (-0.19%)
     
  • GBP/USD

    1.3981
    -0.0003 (-0.0196%)
     
  • BTC-GBP

    39,973.69
    -555.02 (-1.37%)
     
  • CMC Crypto 200

    1,262.19
    -36.76 (-2.83%)
     
  • S&P 500

    4,163.26
    -22.21 (-0.53%)
     
  • DOW

    34,077.63
    -123.04 (-0.36%)
     
  • CRUDE OIL

    63.40
    +0.02 (+0.03%)
     
  • GOLD FUTURES

    1,772.90
    +2.30 (+0.13%)
     
  • NIKKEI 225

    29,100.38
    -584.99 (-1.97%)
     
  • HANG SENG

    29,135.73
    +29.58 (+0.10%)
     
  • DAX

    15,246.04
    -122.35 (-0.80%)
     
  • CAC 40

    6,211.14
    -85.55 (-1.36%)
     

Diabetes Injection Pens Market to Reach $11.3 Billion by 2027

ReportLinker
·28-min read

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 8. - Influencer Pool: 3199. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, March 31, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Diabetes Injection Pens Industry" - https://www.reportlinker.com/p06044532/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.

Abstract:
- Global Diabetes Injection Pens Market to Reach $11.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Diabetes Injection Pens estimated at US$7.2 Billion in the year 2020, is projected to reach a revised size of US$11.3 Billion by 2027, growing at aCAGR of 6.7% over the period 2020-2027. Type I Diabetes, one of the segments analyzed in the report, is projected to record 6.5% CAGR and reach US$6.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Type II Diabetes segment is readjusted to a revised 6.9% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 10.1% CAGR
- The Diabetes Injection Pens market in the U.S. is estimated at US$2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2027 trailing a CAGR of 10.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

- Select Competitors (Total 43 Featured) -

  • AstraZeneca PLC

  • Becton, Dickinson and Company

  • Biocon Ltd.

  • Eli Lilly and Company

  • Jiangsu Delfu medical device Co., Ltd.

  • Novo Nordisk A/S

  • Owen Mumford Ltd.

  • Wockhardt Ltd.




Read the full report: https://www.reportlinker.com/p06044532/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Diabetes Injection
Pens by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Diabetes Injection Pens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Diabetes Injection Pens
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Type I Diabetes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Type I Diabetes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Type I Diabetes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Type II Diabetes
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Type II Diabetes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Type II Diabetes by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Insulin Pens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Insulin Pens by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Insulin Pens by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Insulin Pen
Needles by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Insulin Pen Needles by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Insulin Pen Needles by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Reusable Pens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Reusable Pens by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Reusable Pens by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Disposable Pens
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Disposable Pens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Disposable Pens by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 22: USA Current & Future Analysis for Diabetes Injection
Pens by Indication - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 23: USA Historic Review for Diabetes Injection Pens by
Indication - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: USA 15-Year Perspective for Diabetes Injection Pens
by Indication - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

Table 25: USA Current & Future Analysis for Diabetes Injection
Pens by Product Type - Insulin Pens and Insulin Pen Needles -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Diabetes Injection Pens by
Product Type - Insulin Pens and Insulin Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Diabetes Injection Pens
by Product Type - Percentage Breakdown of Value Sales for
Insulin Pens and Insulin Pen Needles for the Years 2012, 2020 &
2027

Table 28: USA Current & Future Analysis for Diabetes Injection
Pens by Form - Reusable Pens and Disposable Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 29: USA Historic Review for Diabetes Injection Pens by
Form - Reusable Pens and Disposable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 30: USA 15-Year Perspective for Diabetes Injection Pens
by Form - Percentage Breakdown of Value Sales for Reusable Pens
and Disposable Pens for the Years 2012, 2020 & 2027

CANADA
Table 31: Canada Current & Future Analysis for Diabetes
Injection Pens by Indication - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 32: Canada Historic Review for Diabetes Injection Pens by
Indication - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 33: Canada 15-Year Perspective for Diabetes Injection
Pens by Indication - Percentage Breakdown of Value Sales for
Type I Diabetes and Type II Diabetes for the Years 2012, 2020 &
2027

Table 34: Canada Current & Future Analysis for Diabetes
Injection Pens by Product Type - Insulin Pens and Insulin Pen
Needles - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Diabetes Injection Pens by
Product Type - Insulin Pens and Insulin Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Diabetes Injection
Pens by Product Type - Percentage Breakdown of Value Sales for
Insulin Pens and Insulin Pen Needles for the Years 2012, 2020 &
2027

Table 37: Canada Current & Future Analysis for Diabetes
Injection Pens by Form - Reusable Pens and Disposable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Diabetes Injection Pens by
Form - Reusable Pens and Disposable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 39: Canada 15-Year Perspective for Diabetes Injection
Pens by Form - Percentage Breakdown of Value Sales for Reusable
Pens and Disposable Pens for the Years 2012, 2020 & 2027

JAPAN
Table 40: Japan Current & Future Analysis for Diabetes
Injection Pens by Indication - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for Diabetes Injection Pens by
Indication - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Diabetes Injection Pens
by Indication - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

Table 43: Japan Current & Future Analysis for Diabetes
Injection Pens by Product Type - Insulin Pens and Insulin Pen
Needles - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 44: Japan Historic Review for Diabetes Injection Pens by
Product Type - Insulin Pens and Insulin Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for Diabetes Injection Pens
by Product Type - Percentage Breakdown of Value Sales for
Insulin Pens and Insulin Pen Needles for the Years 2012, 2020 &
2027

Table 46: Japan Current & Future Analysis for Diabetes
Injection Pens by Form - Reusable Pens and Disposable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Diabetes Injection Pens by
Form - Reusable Pens and Disposable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 48: Japan 15-Year Perspective for Diabetes Injection Pens
by Form - Percentage Breakdown of Value Sales for Reusable Pens
and Disposable Pens for the Years 2012, 2020 & 2027

CHINA
Table 49: China Current & Future Analysis for Diabetes
Injection Pens by Indication - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 50: China Historic Review for Diabetes Injection Pens by
Indication - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 51: China 15-Year Perspective for Diabetes Injection Pens
by Indication - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

Table 52: China Current & Future Analysis for Diabetes
Injection Pens by Product Type - Insulin Pens and Insulin Pen
Needles - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 53: China Historic Review for Diabetes Injection Pens by
Product Type - Insulin Pens and Insulin Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 54: China 15-Year Perspective for Diabetes Injection Pens
by Product Type - Percentage Breakdown of Value Sales for
Insulin Pens and Insulin Pen Needles for the Years 2012, 2020 &
2027

Table 55: China Current & Future Analysis for Diabetes
Injection Pens by Form - Reusable Pens and Disposable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Diabetes Injection Pens by
Form - Reusable Pens and Disposable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 57: China 15-Year Perspective for Diabetes Injection Pens
by Form - Percentage Breakdown of Value Sales for Reusable Pens
and Disposable Pens for the Years 2012, 2020 & 2027

EUROPE
Table 58: Europe Current & Future Analysis for Diabetes
Injection Pens by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 59: Europe Historic Review for Diabetes Injection Pens by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 60: Europe 15-Year Perspective for Diabetes Injection
Pens by Geographic Region - Percentage Breakdown of Value Sales
for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 61: Europe Current & Future Analysis for Diabetes
Injection Pens by Indication - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 62: Europe Historic Review for Diabetes Injection Pens by
Indication - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 63: Europe 15-Year Perspective for Diabetes Injection
Pens by Indication - Percentage Breakdown of Value Sales for
Type I Diabetes and Type II Diabetes for the Years 2012, 2020 &
2027

Table 64: Europe Current & Future Analysis for Diabetes
Injection Pens by Product Type - Insulin Pens and Insulin Pen
Needles - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Diabetes Injection Pens by
Product Type - Insulin Pens and Insulin Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 66: Europe 15-Year Perspective for Diabetes Injection
Pens by Product Type - Percentage Breakdown of Value Sales for
Insulin Pens and Insulin Pen Needles for the Years 2012, 2020 &
2027

Table 67: Europe Current & Future Analysis for Diabetes
Injection Pens by Form - Reusable Pens and Disposable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Diabetes Injection Pens by
Form - Reusable Pens and Disposable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 69: Europe 15-Year Perspective for Diabetes Injection
Pens by Form - Percentage Breakdown of Value Sales for Reusable
Pens and Disposable Pens for the Years 2012, 2020 & 2027

FRANCE
Table 70: France Current & Future Analysis for Diabetes
Injection Pens by Indication - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 71: France Historic Review for Diabetes Injection Pens by
Indication - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 72: France 15-Year Perspective for Diabetes Injection
Pens by Indication - Percentage Breakdown of Value Sales for
Type I Diabetes and Type II Diabetes for the Years 2012, 2020 &
2027

Table 73: France Current & Future Analysis for Diabetes
Injection Pens by Product Type - Insulin Pens and Insulin Pen
Needles - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 74: France Historic Review for Diabetes Injection Pens by
Product Type - Insulin Pens and Insulin Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 75: France 15-Year Perspective for Diabetes Injection
Pens by Product Type - Percentage Breakdown of Value Sales for
Insulin Pens and Insulin Pen Needles for the Years 2012, 2020 &
2027

Table 76: France Current & Future Analysis for Diabetes
Injection Pens by Form - Reusable Pens and Disposable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Diabetes Injection Pens by
Form - Reusable Pens and Disposable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 78: France 15-Year Perspective for Diabetes Injection
Pens by Form - Percentage Breakdown of Value Sales for Reusable
Pens and Disposable Pens for the Years 2012, 2020 & 2027

GERMANY
Table 79: Germany Current & Future Analysis for Diabetes
Injection Pens by Indication - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 80: Germany Historic Review for Diabetes Injection Pens
by Indication - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 81: Germany 15-Year Perspective for Diabetes Injection
Pens by Indication - Percentage Breakdown of Value Sales for
Type I Diabetes and Type II Diabetes for the Years 2012, 2020 &
2027

Table 82: Germany Current & Future Analysis for Diabetes
Injection Pens by Product Type - Insulin Pens and Insulin Pen
Needles - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 83: Germany Historic Review for Diabetes Injection Pens
by Product Type - Insulin Pens and Insulin Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 84: Germany 15-Year Perspective for Diabetes Injection
Pens by Product Type - Percentage Breakdown of Value Sales for
Insulin Pens and Insulin Pen Needles for the Years 2012, 2020 &
2027

Table 85: Germany Current & Future Analysis for Diabetes
Injection Pens by Form - Reusable Pens and Disposable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Diabetes Injection Pens
by Form - Reusable Pens and Disposable Pens Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 87: Germany 15-Year Perspective for Diabetes Injection
Pens by Form - Percentage Breakdown of Value Sales for Reusable
Pens and Disposable Pens for the Years 2012, 2020 & 2027

ITALY
Table 88: Italy Current & Future Analysis for Diabetes
Injection Pens by Indication - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 89: Italy Historic Review for Diabetes Injection Pens by
Indication - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 90: Italy 15-Year Perspective for Diabetes Injection Pens
by Indication - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

Table 91: Italy Current & Future Analysis for Diabetes
Injection Pens by Product Type - Insulin Pens and Insulin Pen
Needles - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 92: Italy Historic Review for Diabetes Injection Pens by
Product Type - Insulin Pens and Insulin Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 93: Italy 15-Year Perspective for Diabetes Injection Pens
by Product Type - Percentage Breakdown of Value Sales for
Insulin Pens and Insulin Pen Needles for the Years 2012, 2020 &
2027

Table 94: Italy Current & Future Analysis for Diabetes
Injection Pens by Form - Reusable Pens and Disposable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 95: Italy Historic Review for Diabetes Injection Pens by
Form - Reusable Pens and Disposable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 96: Italy 15-Year Perspective for Diabetes Injection Pens
by Form - Percentage Breakdown of Value Sales for Reusable Pens
and Disposable Pens for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 97: UK Current & Future Analysis for Diabetes Injection
Pens by Indication - Type I Diabetes and Type II Diabetes -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 98: UK Historic Review for Diabetes Injection Pens by
Indication - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 99: UK 15-Year Perspective for Diabetes Injection Pens by
Indication - Percentage Breakdown of Value Sales for Type I
Diabetes and Type II Diabetes for the Years 2012, 2020 & 2027

Table 100: UK Current & Future Analysis for Diabetes Injection
Pens by Product Type - Insulin Pens and Insulin Pen Needles -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 101: UK Historic Review for Diabetes Injection Pens by
Product Type - Insulin Pens and Insulin Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 102: UK 15-Year Perspective for Diabetes Injection Pens
by Product Type - Percentage Breakdown of Value Sales for
Insulin Pens and Insulin Pen Needles for the Years 2012, 2020 &
2027

Table 103: UK Current & Future Analysis for Diabetes Injection
Pens by Form - Reusable Pens and Disposable Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 104: UK Historic Review for Diabetes Injection Pens by
Form - Reusable Pens and Disposable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 105: UK 15-Year Perspective for Diabetes Injection Pens
by Form - Percentage Breakdown of Value Sales for Reusable Pens
and Disposable Pens for the Years 2012, 2020 & 2027

SPAIN
Table 106: Spain Current & Future Analysis for Diabetes
Injection Pens by Indication - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 107: Spain Historic Review for Diabetes Injection Pens by
Indication - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 108: Spain 15-Year Perspective for Diabetes Injection
Pens by Indication - Percentage Breakdown of Value Sales for
Type I Diabetes and Type II Diabetes for the Years 2012, 2020 &
2027

Table 109: Spain Current & Future Analysis for Diabetes
Injection Pens by Product Type - Insulin Pens and Insulin Pen
Needles - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 110: Spain Historic Review for Diabetes Injection Pens by
Product Type - Insulin Pens and Insulin Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 111: Spain 15-Year Perspective for Diabetes Injection
Pens by Product Type - Percentage Breakdown of Value Sales for
Insulin Pens and Insulin Pen Needles for the Years 2012, 2020 &
2027

Table 112: Spain Current & Future Analysis for Diabetes
Injection Pens by Form - Reusable Pens and Disposable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 113: Spain Historic Review for Diabetes Injection Pens by
Form - Reusable Pens and Disposable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 114: Spain 15-Year Perspective for Diabetes Injection
Pens by Form - Percentage Breakdown of Value Sales for Reusable
Pens and Disposable Pens for the Years 2012, 2020 & 2027

RUSSIA
Table 115: Russia Current & Future Analysis for Diabetes
Injection Pens by Indication - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 116: Russia Historic Review for Diabetes Injection Pens
by Indication - Type I Diabetes and Type II Diabetes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 117: Russia 15-Year Perspective for Diabetes Injection
Pens by Indication - Percentage Breakdown of Value Sales for
Type I Diabetes and Type II Diabetes for the Years 2012, 2020 &
2027

Table 118: Russia Current & Future Analysis for Diabetes
Injection Pens by Product Type - Insulin Pens and Insulin Pen
Needles - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 119: Russia Historic Review for Diabetes Injection Pens
by Product Type - Insulin Pens and Insulin Pen Needles Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 120: Russia 15-Year Perspective for Diabetes Injection
Pens by Product Type - Percentage Breakdown of Value Sales for
Insulin Pens and Insulin Pen Needles for the Years 2012, 2020 &
2027

Table 121: Russia Current & Future Analysis for Diabetes
Injection Pens by Form - Reusable Pens and Disposable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 122: Russia Historic Review for Diabetes Injection Pens
by Form - Reusable Pens and Disposable Pens Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 123: Russia 15-Year Perspective for Diabetes Injection
Pens by Form - Percentage Breakdown of Value Sales for Reusable
Pens and Disposable Pens for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 124: Rest of Europe Current & Future Analysis for
Diabetes Injection Pens by Indication - Type I Diabetes and
Type II Diabetes - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 125: Rest of Europe Historic Review for Diabetes
Injection Pens by Indication - Type I Diabetes and Type II
Diabetes Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 126: Rest of Europe 15-Year Perspective for Diabetes
Injection Pens by Indication - Percentage Breakdown of Value
Sales for Type I Diabetes and Type II Diabetes for the Years
2012, 2020 & 2027

Table 127: Rest of Europe Current & Future Analysis for
Diabetes Injection Pens by Product Type - Insulin Pens and
Insulin Pen Needles - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 128: Rest of Europe Historic Review for Diabetes
Injection Pens by Product Type - Insulin Pens and Insulin Pen
Needles Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 129: Rest of Europe 15-Year Perspective for Diabetes
Injection Pens by Product Type - Percentage Breakdown of Value
Sales for Insulin Pens and Insulin Pen Needles for the Years
2012, 2020 & 2027

Table 130: Rest of Europe Current & Future Analysis for
Diabetes Injection Pens by Form - Reusable Pens and Disposable
Pens - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 131: Rest of Europe Historic Review for Diabetes
Injection Pens by Form - Reusable Pens and Disposable Pens
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 132: Rest of Europe 15-Year Perspective for Diabetes
Injection Pens by Form - Percentage Breakdown of Value Sales
for Reusable Pens and Disposable Pens for the Years 2012, 2020 &
2027

ASIA-PACIFIC
Table 133: Asia-Pacific Current & Future Analysis for Diabetes
Injection Pens by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 134: Asia-Pacific Historic Review for Diabetes Injection
Pens by Geographic Region - Australia, India, South Korea and
Rest of Asia-Pacific Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 135: Asia-Pacific 15-Year Perspective for Diabetes
Injection Pens by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 136: Asia-Pacific Current & Future Analysis for Diabetes
Injection Pens by Indication - Type I Diabetes and Type II
Diabetes - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 137: Asia-Pacific Historic Review for Diabetes Injection
Pens by Indication - Type I Diabetes and Type II Diabetes
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 138: Asia-Pacific 15-Year Perspective for Diabetes
Injection Pens by Indication - Percentage Breakdown of Value
Sales for Type I Diabetes and Type II Diabetes for the Years
2012, 2020 & 2027

Table 139: Asia-Pacific Current & Future Analysis for Diabetes
Injection Pens by Product Type - Insulin Pens and Insulin Pen
Needles - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 140: Asia-Pacific Historic Review for Diabetes Injection
Pens by Product Type - Insulin Pens and Insulin Pen Needles
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 141: Asia-Pacific 15-Year Perspective for Diabetes
Injection Pens by Product Type - Percentage Breakdown of Value
Sales for Insulin Pens and Insulin Pen Needles for the Years
2012, 2020 & 2027

Table 142: Asia-Pacific Current & Future Analysis for Diabetes
Injection Pens by Form - Reusable Pens and Disposable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 143: Asia-Pacific Historic Review for Diabetes Injection
Pens by Form - Reusable Pens and Disposable Pens Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 144: Asia-Pacific 15-Year Perspective for Diabetes
Injection Pens by Form - Percentage Breakdown of Value Sales

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06044532/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001